Skip to Content

  • Search

View Additional Section Content

GOG-0229L - A Phase II Trial Of AMG 386 (IND #111071), A Selective Angiopoietin 1/2 Neutralizing Peptibody, In Patients With Persistent/Recurrent Carcinoma Of The Endometrium

Clinical Trial Categories

  • Corpus Uterus/Endometrial Cancer
Hanjani Institute for Gynecologic Oncology at 215-885-0220


  • Hanjani Institute for Gynecologic Oncology
    The Rosenfeld Cancer Center
    1200 Old York Rd, AMH - 1 Widener
    Abington, PA 19001
    Office: 215-885-0220
    Fax: 215-576-0740

Find a Physician
Search Our Directory


Schedule a Test
Request an Appointment


Clinical Trials Details